Product Images Bupropion Hydrochloride

This is a medication with NDC code 50268-141-15, named BuPROPlon Hcl, which is an extended-release tablet that is intended for use once per day under the direction of a physician. There are fifty tablets contained in the package, which is labeled as "rx only" and has a medication guide included. Each tablet includes Bupropion Hydrochloride, and this medication should not be used in combination with other medications that contain bupropin hydrochloride. The usual dosage is one tablet daily, and all drugs should be kept out of the reach of children. The manufacturer is AVKARE, Inc. The storage conditions for this medication should be at a controlled room temperature of 20-25°C (68-77°F).*

This is a prescription medication with the NDC code 50268-140-13. It contains 30 extended-release tablets of Bupropion Hydrochloride USP (XL) with a strength of 150mg. The usual dosage is one tablet per day, as directed by a physician. It is important to store the medication at a controlled room temperature of 20° to 25°C (68°F to 77°F) and keep it out of reach of children. The drug should not be taken with Zyban or any other medicine containing bupropion hydrochloride. The package insert contains full prescribing information. The medication is produced by AvKare, Inc. located in Pulaski, TH.*

The text describes a table showing the rates of discontinuation of depression treatment due to adverse reactions. The table compares placebo medication to two different dosages of sustained-release bupropion HCl, with the adverse reactions listed being rash, nausea, and agitation. The text is legible and properly transcribed.*

This is a comparison table that shows the incidence of weight gain or weight loss in SAD Trials using Bupropion HCl Extended-Release. The table compares the weight change between Bupropion HCL Extended-Release and Placebo groups in which 1% of people gained more than 5lbs and 2% of people lost more than 5lbs using Bupropion HCL Extended-Release.*